Skip to main content
Clinical Trials/JPRN-UMIN000002487
JPRN-UMIN000002487
Completed
Phase 4

The effect of aggressive antihypertensive therapy in hypertensive patients with left ventricular diastolic dysfunction - The effect of aggressive antihypertensive therapy in hypertensive patients with left ventricular diastolic dysfunction

Kawasaki Medical School0 sites60 target enrollmentNovember 1, 2009
ConditionsHypertension

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Hypertension
Sponsor
Kawasaki Medical School
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 1, 2009
End Date
November 1, 2011
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients with secondary hypertension 2\) Patients with uncontrolled hypertension (DBP\>\=120mmHg) 3\) Patients with uncontrolled diabetes (HbA1c\>\=8\.0%) 4\) Patients with cardiac insufficiency (over NYHA grade III) 5\) Patients with renal failure (serum creatinine\>\=2\.0mg/dl) 6\) Patients with liver dysfunction (GOT or GPT\>\=100IU/L) 7\) Patients with a previous history of gout attack or uncontrolled hyperuricemia (UA\>\=8\.0mg/dl) 8\) Patients with hyperkalemia (K\>\=5\.5mEq/L) 9\) Pregnant or breast feeding female patients, including one trying to conceive pregnancy during the planned study period 10\) Patients with a history of hypersensitivity to ingredients of the study drugs 11\) Patients who are considered not eligible for the study by the attending doctor due to medical reasons

Outcomes

Primary Outcomes

Not specified

Similar Trials